Imaging of ependymomas: MRI and CT by Yuh, E. L. et al.
INVITED PAPER
Imaging of ependymomas: MRI and CT
E. L. Yuh & A. J. Barkovich & N. Gupta
Received: 10 March 2009 /Published online: 10 April 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract The imaging features of intracranial and spinal
ependymoma are reviewed with an emphasis on conven-
tional magnetic resonance imaging (MRI), perfusion MRI
and proton magnetic resonance spectroscopy, and computed
tomography. Imaging manifestations of leptomeningeal
dissemination of disease are described. Finally, salient
imaging features obtained in the postoperative period to
evaluate completeness of surgical resection, and thereafter
for long-term surveillance for disease recurrence, are
reviewed.
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Introduction
Magnetic resonance imaging (MRI) is the primary imaging
modality used for the assessment of both intracranial and
spinal ependymoma. Although computed tomography (CT)
provides better demonstration of small or subtle calcifica-
tions within tumors, MRI provides superior delineation of
the extent of tumor due to its greater soft tissue contrast,
multiplanar imaging capability, and ability to obtain
complementary information with T1- and T2-weighted
sequences. Finally, MRI avoids the use of ionizing
radiation, a desirable strategy in children who are more
susceptible to radiation-induced malignancy than adults [5].
The standard MRI protocol for pediatric intracranial
tumors at UCSF includes volumetric fluid-attenuated
inversion recovery (FLAIR), sagittal and axial T1-, axial
T2-, axial diffusion-, and postcontrast axial and coronal T1-
weighted sequences. In suspected infratentorial tumors,
postcontrast sagittal T1-weighted images are also obtained.
Susceptibility-weighted perfusion MRI and proton magnet-
ic resonance (MR) spectroscopy are performed in a limited
number of cases, usually to distinguish posttreatment
changes from recurrent tumor in the posttherapeutic setting,
or occasionally when the neoplastic nature of a primary
lesion is in question. MRI of pediatric spinal tumors
generally consists of sagittal T1-, T2-, and postgadolinium
T1-weighted sequences, with axial T2- and postgadolinium
T1-weighted images through the lesion.
Magnetic resonance imaging and computed tomography
of intracranial tumors
General
Intracranial ependymomas, including both infra- and supra-
tentorial ependymomas, generally demonstrate low T1,
high T2, and intermediate-to-high FLAIR signal intensity
relative to both gray and white matter (Figs. 1, 2, and 3).
These characteristics have been attributed to the high
proportion of ependymomas with intracellular myxoid
accumulation and cyst formation [9]. As a result, they are
often conspicuous on T2-weighted and FLAIR sequences
and are also usually visible on unenhanced T1-weighted
images (Figs. 1 and 2).
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and T2 hyperintense relative to brain parenchyma, both T1
and T2 signal intensity are heterogeneous within the tumor.
This is particularly true for supratentorial ependymomas,
which have a greater propensity than their infratentorial
counterparts for extensive cyst formation [2]( F i g .3). This
may be attributable to their later clinical presentation and
larger size at the time of discovery. Cystic areas of a lesion
may follow fluid signal intensity on both T2-weighted and
FLAIR sequences or may remain hyperintense on FLAIR
due to proteinaceous fluid contents. Calcifications, which are
common in both supratentorial and infratentorial ependymo-
mas (approximately 50%), and old hemorrhage are generally
very low in signal intensity on all MRI sequences.
On postgadolinium T1-weighted images, there is usually
avid enhancement of the soft tissue components of the
tumor, intermixed with poorly enhancing or nonenhancing
areas. A minority of lesions demonstrates little or no
postgadolinium enhancement despite being composed of
mostly soft tissue (Fig. 4).
Diffusion-weighted imaging (DWI) is based on the
random movement of water molecules in tissue. Tissues in
which water diffusion is reduced demonstrate high DWI
signal and low apparent diffusion coefficient (ADC). DWI
demonstrates reduced diffusion within the soft tissue
components of some ependymomas (Fig. 5), presumably
due to high cellularity of some lesions. Diffusivity of
ependymomas is generally intermediate between that of
pilocytic astrocytomas and primitive neuroectodermal
tumors [18]. However, diffusivity values are not completely
reliable in making histologic diagnoses.
Perfusion MRI and proton MR spectroscopy are per-
formed in only a limited number of cases, usually to
distinguish treatment changes from recurrent tumor, or
occasionally when the neoplastic nature of a lesion is in
question. Perfusion MRI can be performed using several
techniques, including T2*-weighted dynamic susceptibility
and fast spoiled gradient-echo techniques, which require
bolus administration of gadolinium contrast, and arterial
spin labeling, which does not require gadolinium. Perfusion
MRI is challenging in infants and young children for
several reasons including the difficulty of obtaining
proximal intravenous access, the use of small intravenous
catheters that limit injection rates, the necessity of using
Fig. 1 Classic MRI appearance
of posterior fossa ependymoma
in a 2-year-old child. Fourth
ventricular mass demonstrates a
low T1 signal intensity, b pre-
dominantly solid enhancement
on postgadolinium T1-weighted
images, and c heterogeneous T2
hyperintensity. d Sagittal post-
gadolinium T1-weighted image
demonstrates extension inferior
through the foramen of Magen-
die onto the posterior aspect of
the upper cervical cord, a feature
that is highly suggestive of
ependymoma
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artifact [3]. When performed, perfusion MRI of ependy-
moma generally demonstrates markedly elevated cerebral
blood volume and, unlike many other glial neoplasms, poor
return to baseline that may be attributable to fenestrated
blood vessels and an incomplete blood–brain barrier [22]
(Figs. 5 and 6).
Proton MR spectroscopy usually demonstrates elevated
choline and reduced N-acetylaspartate (NAA) in ependymo-
mas, as in many other brain tumors. Although the use of MR
spectroscopy for prospective differentiation of infratentorial
ependymoma from medulloblastoma has been investigated,
the variability in choline/NAA ratios within each tumor
histology results in considerable overlap, and MR spectros-
copy is currently used primarily to differentiate tumor
recurrence from postradiation or posttreatment change rather
than to confirm a histologic diagnosis [3].
MRI is the recommended initial brain imaging modality
of choice not only for intracranial tumors but also for any
younger child with new neurological signs or symptoms,
except in the setting of acute head trauma [3]. However,
intracranial ependymoma is sometimes initially diagnosed
on head CT. CT demonstrates isodense or mildly hyper-
dense soft tissue portions of the tumor, calcifications in
50% of lesions, hemorrhage in approximately 10% [21],
and often heterogeneous enhancement (Figs. 3a and 5,
inset). CT is generally more sensitive for, and will
demonstrate a greater number of, calcifications than most
MRI sequences, particularly spin echo-type sequences.
However, MRI sequences with increased susceptibility-
associated signal loss, such as diffusion-weighted and
gradient-echo sequences, commonly demonstrate foci of
signal void/loss in areas of coarse/gross calcification or
hemorrhage (Figs. 3 and 5).
Fig. 2 Axial and sagittal
T2-weighted images through a
typical fourth ventricle ependy-
moma demonstrate signal inten-
sity similar to gray matter
throughout most of the lesion.
Extension through the foramina
of Luschka is demonstrated by
black arrowheads in a and white
arrows in b and d, and exten-
sion through foramen of
Magendie by black arrows in e.
Dashed lines in a indicate
planes at which sagittal images
(b, d) are located. The lesion
insinuates around and encases
vessels, as shown in c and f.
Cystic/necrotic areas (black
arrows in a and d) are closer
to cerebrospinal fluid signal
intensity
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Approximately 70% of intracranial ependymomas are infra-
tentorial, arising from differentiated ependymal cells lining
the fourth ventricle and foramina of Luschka. At the time of
clinical presentation, infratentorial ependymomas usually fill
and distend the fourth ventricle, resulting in hydrocephalus
and symptoms of nausea and vomiting in 90% of patients [1,
3]. A highly typical feature of ependymoma is extension
through the foramina of Luschka into the cerebellopontine
angle (15%) and/or inferiorly through the foramen of
Magendie (60%) onto the posterior aspect of the upper
cervical cord (Figs. 1, 2,a n d4). Although this feature is not
entirely pathognomonic, the few medulloblastomas (the main
differential diagnosis for infratentorial ependymoma) that
extend through the fourth ventricular exit foramina [4]s h o w
more bulbous extension rather than thin tongues of tissue
through the foramina as in ependymomas [3]. Ependymomas
often insinuate around and within structures, encasing
vessels and lower cranial nerves, and can cause cranial
neuropathies. In addition to the classic appearance of a fourth
ventricular mass, infratentorial ependymomas can also
present within the cerebellopontine angle, presumably arising
from the rests of ependymal cells therein. Ependymomas
Fig. 3 Supratentorial ependy-
moma in a 10-year-old girl on
a noncontrast CT, b T2-
weighted, c FLAIR, and d–f
postgadolinium T1-weighted
MRI. Unlike posterior fossa
ependymomas, most supratento-
rial ependymomas (70%) are
extraventricular in origin.
Supratentorial ependymomas
usually demonstrate more het-
erogeneous T1 and T2 signal
than their infratentorial counter-
parts, due to a greater tendency
toward cyst formation, calcifi-
cations, and hemorrhage. Avidly
enhancing areas are generally
present, but are often intermixed
with poorly or nonenhancing
areas
1206 Childs Nerv Syst (2009) 25:1203–1213arising from a location not in the midline may have a worse
prognosis than midline lesions, perhaps due to involvement
of critical structures such as cranial nerves [3, 12].
Supratentorial ependymoma
Approximately 30% of intracranial ependymomas are supra-
tentorial. Within the pediatric population, supratentorial
ependymomas are often seen in older childhood [11]. Unlike
posterior fossa ependymomas, most supratentorial ependy-
momas (70%) are extraventricular in origin, arising within
the brain parenchyma of the cerebral hemispheres rather than
from ependymal cells lining the ventricular surfaces. Extra-
ventricular ependymomas are thought to originate from the
rests of ependymal cells that are retained in the brain
parenchyma during embryonic development. They are,
however, often located near the ventricular margins and
may extend into the ventricular system. In addition, in
comparison to posterior fossa tumors, hydrocephalus occurs
relatively late (after development of significant subfalcine
herniation), by which time the tumors are typically large,
with an average size of over 4 cm at presentation (Figs. 3, 5,
and 6)[ 2, 9]. Approximately 30% of supratentorial ependy-
momas arise in an intraventricular location, generally along
t h es u r f a c e so ft h el a t e r a lv e n t r i c l e so ra l o n gt h es e p t u m
pellucidum. Although the ependymal surface area of the
third ventricle is larger than that of the fourth ventricle, third
ventricular ependymomas are rare [10, 13].
Anaplastic ependymoma
The World Health Organization classifies ependymal
tumors into four types: (1) ependymoma (grade 2), (2)
anaplastic ependymoma (grade 3), (3) subependymoma
(grade 1), and (4) myxopapillary ependymoma (grade 1).
Grade 2 ependymomas are further subdivided into four
Fig. 4 Atypical, nonenhancing
ependymoma in a 13-year-old.
a, c, e Homogeneous FLAIR
hyperintensity throughout most
of the lesion, which insinuates
around and encases vessels and
extends through the foramina of
Luschka (arrowheads in e).
Temporal horn dilatation
(arrows in a)) indicates hydro-
cephalus. As shown on postga-
dolinium T1-weighted images in
b, d, and f, this lesion, unlike
most ependymomas, demon-
strates no appreciable enhance-
ment, remaining diffusely
hypointense on postgadolinium
T1-weighted images
Childs Nerv Syst (2009) 25:1203–1213 1207major histologic subtypes: cellular, papillary, clear-cell, and
the rare tanycytic subtype, with these subtypes demonstrat-
ing some variation in prognosis [10, 16]. In comparison to
the more common grade 2 ependymomas, anaplastic
ependymomas have greater incidence of cerebrospinal fluid
dissemination at the time of diagnosis and a poorer
prognosis (Fig. 7)[ 3].
Spinal ependymoma
Ependymoma is the second most common pediatric intra-
medullary spinal tumor after astrocytoma. Ependymomas
constitute 30% of pediatric intramedullary spinal lesions,
while astrocytomas constitute 60%. Most pediatric spinal
ependymomas are WHO grade 2 lesions. Myxopapillary
Fig. 5 Supratentorial ependy-
moma on a postgadolinium T1;
b FLAIR (inset: noncontrast
CT); c diffusion-weighted
images (DWI); d apparent dif-
fusion coefficient; and e perfu-
sion MRI with f cerebral blood
volume measurements. DWI
demonstrates reduced diffusion
within the soft tissue compo-
nents of some ependymomas
due to high cellularity.
Perfusion-weighted imaging
generally demonstrates elevated
blood volume within the tumor,
with poor return to baseline
likely attributable to lack of a
blood–brain barrier. CT demon-
strates isodensity or mild hyper-
density of solid soft tissue
portions of the tumor, often
heterogeneous enhancement on
postcontrast CT (not shown) and
calcifications in 50% of lesions.
Although CT is more sensitive
for calcification than most MRI
sequences, susceptibility-
sensitive diffusion- and
perfusion-weighted sequences in
c and e, as well as gradient-echo
sequences, do commonly dem-
onstrate areas of calcification or
hemorrhage as signal void/loss
1208 Childs Nerv Syst (2009) 25:1203–1213ependymoma, a WHO grade 1 lesion that occurs almost
exclusively within the conus or cauda equina, is more
common in adults, accounting for nearly 50% of adult
spinal ependymomas, but is rare in children, comprising
only 8% to 12% of pediatric spinal ependymomas [3]. As
with their intracranial counterparts, prognosis in pediatric
spinal ependymoma is most dependent on tumor grade,
completeness of resection, and evidence of disseminated
disease at time of diagnosis.
As with their intracranial counterparts and most other
intramedullary tumors, spinal ependymomas generally
demonstrate high T2 and low T1 signal intensity that is
Fig. 6 Supratentorial grade 2
ependymoma in a 12-year-old
girl. a Axial FLAIR, b axial
perfusion MRI, c postcontrast
axial T1, d axial cerebral blood
volume map derived from per-
fusion MRI, e axial ADC coef-
ficient, and f perfusion MRI
T2*-weighted dynamic suscep-
tibility curves
Childs Nerv Syst (2009) 25:1203–1213 1209often heterogeneous (Fig. 8). Contrast enhancement may be
homogeneous or heterogeneous, but some enhancement is
nearly always present. Ependymomas have a greater
tendency than astrocytomas to be located centrally in the
cord, and often demonstrate a sharper margin of enhance-
ment, corresponding to margins of the tumor, than do
astrocytomas [3]. Although seen in only 20% of cases, a
finding of T2 hypointensity along the borders of the lesion,
attributable to remote episodes of hemorrhage, is highly
suggestive of ependymoma [3]. As with their intracranial
counterparts, cerebrospinal fluid (CSF) dissemination at the
time of diagnosis is rare but is somewhat more common
with higher-grade tumors. Perfusion MRI and MR spec-
troscopy are not currently performed on spinal tumors due
to the small axial cross-section of the spinal canal and
susceptibility effects from the surrounding bony spine [3].
Fig. 7 Anaplastic
ependymoma in a 2-month-old
infant who presented with in-
creasing head circumference.
T2-weighted sequences in a
and c and postgadolinium
T1-weighted sequences in b, d,
e, and f. This tumor is charac-
terized by multiple cysts,
heterogeneous postcontrast en-
hancement, and large size
resulting in severe obstructive
hydrocephalus. c, d Upward
extension of the tumor through
the tentorial incisura
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Evidence of spread of ependymoma cells into the CSF is a
key factor in staging, prognosis, and treatment [15]. Sub-
arachnoid spread of disease can be detected by MRI (Fig. 9)
or by CSF cytologic studies. MRI is more sensitive than, and
has replaced, CT myelography in the detection of leptome-
ningeal spread [7] and is also likely more sensitive than CSF
cytology for the detection of subarachnoid spread of primary
brain tumors (though CSF cytology may be more sensitive
for CSF spread of leukemias and lymphomas) [3, 6].
Despite their location close to the ependymal surfaces
of the ventricles and central canal of the spinal cord that
could be expected to lead to a high incidence of
exfoliation into the subarachnoid space, subarachnoid
seeding is relatively uncommon in comparison to other
primary central nervous system neoplasms such as
medulloblastomas and malignant astrocytomas [15]. In
general, CSF seeding is more common in higher-grade
ependymomas, such as anaplastic ependymomas, and in
younger children [15, 17, 19]. CSF spread is also much
more common with infratentorial tumors than with supra-
Fig. 8 Typical spinal ependy-
momas. a–c T2-, T1-, and post-
gadolinium T1-weighted sagittal
images of grade 2 ependymoma
in a 3-year-old boy. d–f T2-,
T1-, and postgadolinium
T1-weighted images of a
myxopapillary (grade 1) epen-
dymoma in a 14-year-old boy
Childs Nerv Syst (2009) 25:1203–1213 1211tentorial tumors [14]. A study of 754 patients with
intracranial ependymomas demonstrated cytologic evi-
dence of CSF spread of disease in 12%, with a lower
incidence (<5%) of symptomatic leptomeningeal disease
[19]. Another study showed positive CSF cytology in only
8% of a series of 26 grade 2 intracranial ependymomas
and 33% of 15 grade 3 anaplastic ependymomas and grade
2/3 ependymomas with anaplastic features [15]. Detect-
able subarachnoid spread of disease at the time of
presentation of grade 2 ependymoma is also much less
common than in medulloblastoma. Rather, when sub-
arachnoid spread does occur, it is often detected at the
time of discovery of disease recurrence. The mean time
from diagnosis to discovery of CSF dissemination is
6.8 years [3, 17].
Imaging manifestations of leptomeningeal spread of
disease in the spine are variable and include smooth
enhancement along the surface of the spinal cord; enhancing
foci in the extramedullary intradural or, occasionally, intra-
medullary space; nerve root thickening, nodularity, or clump-
ing; and thecal sac irregularity. The lumbosacral region,
particularly the most caudal aspect of the thecal sac, is the
most common location for “drop” metastases. MR sensitivity
for leptomeningeal metastases increases with higher doses of
contrast and the use of volumetric gradient-echo imaging to
obtain thin section axial imaging of the spine. Small
metastases on nerve roots can be detected if thin sections
(3 mm or less) are used. Of note, if MRI for assessment of
subarachnoid tumor spread is performed postoperatively, it
should be performed no less than 2 weeks following surgery,
as “leakage” of contrast into the subarachnoid and subdural
space following posterior fossa craniectomy can occur and
mimic leptomeningeal spread of disease [3, 23, 24].
Intracranial imaging manifestations include leptomenin-
geal nodules, masses or smooth enhancement, and commu-
nicating hydrocephalus. Interestingly, intraventricular
nodules and masses often demonstrate little or no enhance-
ment (Fig. 9)[ 3].
Postoperative imaging
As with other intracranial neoplasms, an MRI is obtained
immediately after surgery to evaluate the extent of resection
and periodically thereafter for long-term surveillance for
disease recurrence. Following surgery, a thin rim of enhance-
Fig. 9 Leptomeningeal
and multiple intraventricular
metastases discovered 13
months after treatment of a
posterior fossa ependymoma in
a 2-year-old girl. Although ini-
tial MRI of the lumbar spine
was suggestive of possible lep-
tomeningeal disease, CSF cytol-
ogy was negative. a) Original
coronal FLAIR images at time
of diagnosis. b) Sagittal and c),
d) axial postgadolinium T1-
weighted images of the lumbar
spine at time of diagnosis. e)
Thirteen months later, the re-
section site of the original fourth
ventricular tumor demonstrates
no evidence of locally recurrent
disease. f) However, multiple
intraventricular leptomeningeal
metastases are seen and may
have been attributable to CSF
spread at the time of initial
diagnosis
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the cavity margins beginning as soon as 24 h, which becomes
progressively thicker and more nodular over the next several
days. Therefore, imaging to assess extent of resection should
be performed less than 48 h after surgery [3]. Pregadolinium
T1-weighted sequences are always included to distinguish
perioperative hemorrhage from residual enhancing tumor.
For pediatric patients, a head CT in the immediate
postoperative period after craniotomy is reserved for delayed
recovery from anesthesia or unexpected acute neurologic
deficits or to assess changes in hydrocephalus after shunt
placement [3]. It should not be used as a surrogate for MR
imaging to assess extent of resection.
Following the period after surgery, enhancement along the
resection cavity margins progressively decreases beginning at
approximately 5 weeks and usually resolves completely
within 12 months [3]. Therefore, any new or increasing en-
hancement after approximately 5 weeks after surgery should
raise suspicion for tumor recurrence. New contrast enhance-
ment can also be seen several months to years (typically 4 to
6 months) after radiation therapy and has been attributed to
late delayed injury resulting from permanent damage to blood
vessels [3]. Since recrudescent enhancement is sometimes
attributable to these posttreatment effects rather than recurrent
tumor, proton MR spectroscopy and perfusion MRI can be
helpful adjunct techniques in this setting to aid in the differ-
entiation of tumor recurrence from posttreatment changes. In
particular, necrosis, including that due to radiation injury,
generally demonstrates concomitant reduction of NAA, cho-
line, and creatine peaks, while a new or persistently elevated
choline/NAA ratio raises concern for recurrent tumor.
Although recommendations regarding the duration of sur-
veillance imaging vary [8, 20, 24], periods of up to 10 years
have been suggested for posterior fossa ependymoma.
Because a complete resection is not feasible in many patients
due to insinuation of the tumor around vessels, cranial
nerves, and other critical structures, ependymomas do show
a relatively high recurrence rate [3, 8, 11, 20, 24].
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